Major Autohemotherapy (MAH) Ozone Therapy in Northern VA
Major Autohemotherapy (MAH) is considered the foundational method of medical ozone therapy and has been utilized internationally for decades within integrative medical settings. This provider-directed procedure involves withdrawing a measured amount of blood, exposing it to a controlled medical-grade oxygen–ozone mixture outside the body, and then reinfusing the treated blood through a sterile extracorporeal system.
Because the ozone interacts with the blood externally, ozone gas itself is not directly injected into the bloodstream. Instead, the physiologic response is believed to result from biologically active signaling molecules created during the controlled interaction between ozone and blood components.
In integrative and supportive care settings, MAH is commonly explored in the context of oxygen metabolism, microcirculatory function, oxidative signaling pathways, immune-system communication, and physiologic stress-response mechanisms. Compared to more intensive ozone procedures such as 10-Pass therapy or EBOO, MAH is often considered a foundational or lower-intensity systemic ozone protocol within provider-directed care plans.
At NOVA IV Therapy, all ozone therapies are administered within a medically supervised environment using calibrated medical equipment, sterile protocols, and individualized provider evaluation.
Clinical Considerations & Physiological Role
Oxidative Signaling & Adaptive Antioxidant Response:
When ozone interacts with blood outside the body, it rapidly forms reactive oxygen species (ROS) and lipid oxidation products (LOPs), which are studied within ozone medicine for their role in cellular signaling and adaptive antioxidant pathway activation. These signaling mechanisms are commonly discussed in the context of oxidative preconditioning and physiologic stress adaptation.
Oxygen Utilization & Microcirculatory Dynamics:
MAH therapy is commonly discussed within integrative ozone medicine in relation to oxygen metabolism, nitric oxide signaling, rheologic blood-flow characteristics, and microcirculatory function associated with tissue oxygen utilization.
Immune System Communication Pathways:
Ozone-generated signaling molecules are being studied for their interaction with immune-system communication pathways and inflammatory signaling mechanisms. Clinical interpretation and application vary depending on provider training, treatment philosophy, and patient-specific considerations.
Systemic Physiologic Signaling:
Because ozonated blood is reinfused systemically after treatment, MAH is commonly explored within broader integrative ozone strategies involving adaptive physiologic signaling, oxygen metabolism, and systemic circulatory exposure.
Common Reasons Patients Explore MAH Ozone Therapy
Patients may explore MAH ozone therapy within integrative care plans in the context of:
- Chronic fatigue and reduced physical resilience.
- Oxidative stress and recovery.
- Immune system support.
- Circulatory and oxygenation-related wellness concerns.
- Environmental stressor support.
- Inflammatory or recovery-focused wellness strategies.
- Supportive care strategies during periods of increased physiologic stress.
- Integrative approaches for complex or long-standing health concerns.
- Low immune resilience and physiologic recovery concerns.
These therapies are used as resilience-focused options and are not intended to replace conventional medical care, emergency treatment, oncology care, infectious disease management, or appropriate specialist evaluation.
Why Major Autohemotherapy (MAH)?
Unlike oral supplements or conventional hydration therapies, MAH utilizes a controlled extracorporeal blood interaction process designed to generate biologically active oxidative signaling molecules before the treated blood is reinfused into systemic circulation.
The clinical advantages of MAH therapy include:
- Controlled Oxidative Preconditioning: When ozone interacts with blood outside the body, it rapidly generates reactive oxygen species (ROS) and lipid oxidation products (LOPs). Within ozone medicine, these short-lived signaling molecules are studied for their role in activating adaptive antioxidant pathways and cellular stress-response mechanisms through a process commonly referred to as oxidative preconditioning or hormesis.
- Systemic Circulatory Distribution: Once reinfused, the ozonated blood circulates systemically throughout the vascular system. Integrative ozone medicine commonly discusses MAH in the context of oxygen metabolism, microcirculatory dynamics, nitric oxide signaling, and rheologic blood-flow characteristics associated with tissue oxygen utilization.
- Lower-Intensity Systemic Ozone Exposure: Compared to higher-intensity ozone procedures such as 10-Pass therapy or EBOO, MAH utilizes a single extracorporeal blood-treatment cycle with lower cumulative ozone exposure. Because of this, MAH is often incorporated as a foundational or introductory systemic ozone protocol prior to more intensive extracorporeal ozone therapies.
Proudly Serving the D.C., Maryland, Virginia Metro Region
NOVA IV Therapy is conveniently located off Route 7 in Loudoun County, making it easily accessible for patients throughout Sterling, Ashburn, Reston, Herndon, Tysons, Leesburg, Great Falls and the surrounding areas. Designed with comfort and patient experience in mind, our space enables us to offer integrative wellness services and IV therapies in one cohesive environment.
NOVA IV Therapy welcomes patients throughout Northern Virginia, Loudoun County, Fairfax County, and the greater Washington D.C. metro region, including but not limited to: Arlington, Alexandria, Falls Church, Fairfax, Vienna, McLean, Tysons, Reston, Leesburg, Springfield, Herndon, Sterling, Ashburn, Gainesville, Haymarket, Chantilly, Centreville, Clifton, Burke, Great Falls, Oakton, Middleburg, Winchester.
NOVA IV Therapy welcomes patients from Maryland, including but not limited to: Silver Spring, Bethesda, Rockville, Gaithersburg, Germantown, Potomac, Chevy Chase.
Medical & Regulatory Disclaimer
Nutrient IV therapies and ozone-based therapies, including Major Autohemotherapy (MAH), 10-Pass, Extracorporeal Blood Oxygenation and Ozonation (EBOO), ozone limb bagging, and use of the Hemealumen device, are elective wellness services offered under the clinical judgment of licensed providers.
These therapies and protocols are not approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Statements regarding these services have not been evaluated by the FDA.
These services may be described as investigational, adjunctive, or alternative in nature. No claims are made regarding therapeutic outcomes, efficacy, or specific health benefits, and individual results may vary.
The information provided on this website is for general educational and informational purposes only and is not intended as medical advice. Use of this website does not create a provider–patient relationship. Clinical decisions and medical advice are provided only in the context of an in-person consultation with a licensed healthcare professional.
All medical procedures carry inherent risks. You are responsible for discussing potential risks, benefits, contraindications, and alternatives with a qualified healthcare provider before electing to pursue any service.